Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABSI

Absci Corp

May 10 • 04:00PM ET

4.91

Dollar change -0.23
Percentage change -4.47	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKG VTI VXF SCHA IWC ITOT AVSC SCHB DFAT AVUS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.20	Insider Own	23.53%	Shs Outstand	93.09M	Perf Week	-3.35%
Market Cap	555.22M	Forward P/E	-	EPS next Y	-0.77	Insider Trans	0.84%	Shs Float	86.48M	Perf Month	-19.31%
Income	-110.57M	PEG	-	EPS next Q	-0.21	Inst Own	33.93%	Short Float	9.34%	Perf Quarter	14.19%
Sales	5.72M	P/S	97.07	EPS this Y	29.72%	Inst Trans	3.16%	Short Ratio	5.72	Perf Half Y	261.03%
Book/sh	1.89	P/B	2.59	EPS next Y	9.29%	ROA	-38.58%	Short Interest	8.08M	Perf Year	274.81%
Cash/sh	1.01	P/C	4.88	EPS next 5Y	23.30%	ROE	-49.08%	52W Range	1.11 - 6.72	Perf YTD	16.90%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-46.78%	ROI	-59.27%	52W High	-26.93%	Beta	2.40
Dividend TTM	-	Quick Ratio	4.08	Sales past 5Y	37.94%	Gross Margin	-144.82%	52W Low	341.90%	ATR (14)	0.37
Dividend Ex-Date	-	Current Ratio	4.08	EPS Y/Y TTM	-4.03%	Oper. Margin	-1638.34%	RSI (14)	47.34	Volatility	5.58% 7.19%
Employees	156	Debt/Eq	0.09	Sales Y/Y TTM	-0.50%	Profit Margin	-1933.65%	Recom	1.33	Target Price	8.60
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	-19.28%	Payout	-	Rel Volume	0.50	Prev Close	5.14
Sales Surprise	-62.44%	EPS Surprise	-17.65%	Sales Q/Q	-78.29%	Earnings	May 14 BMO	Avg Volume	1.41M	Price	4.91
SMA20	-1.32%	SMA50	-5.18%	SMA200	57.76%	Trades		Volume	708,965	Change	-4.47%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-14-24	Initiated	Scotiabank	Sector Outperform	$13
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$3
May-04-23	Initiated	H.C. Wainwright	Buy	$4
Aug-12-22	Downgrade	JP Morgan	Overweight → Underweight
Jul-18-22	Initiated	Truist	Buy	$8
Mar-02-22	Resumed	Cowen	Market Perform
Feb-01-22	Initiated	Berenberg	Buy	$28
Nov-10-21	Downgrade	BofA Securities	Neutral → Underperform	$10
Oct-15-21	Resumed	Cowen	Market Perform
Aug-16-21	Initiated	Stifel	Hold	$28
Aug-16-21	Initiated	Credit Suisse	Outperform	$40
Aug-16-21	Initiated	Cowen	Market Perform
Aug-16-21	Initiated	BofA Securities	Neutral	$26

Show Previous Ratings

May-07-24 09:13AM	Absci (ABSI) to Report Q1 Earnings: Here's What to Expect (Zacks)
Apr-16-24 08:00AM	Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 (GlobeNewswire)
Apr-10-24 11:07AM	Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last? (Zacks) -7.67%
Mar-28-24 04:05PM	Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-23-24 05:31AM	Absci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net Loss (GuruFocus.com)
02:52PM	Loading…
Mar-21-24 02:52PM	ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
07:30AM	Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results (GlobeNewswire)
Mar-12-24 05:34PM	11 Stocks Insiders are Buying Now (Insider Monkey) +5.11%
Mar-06-24 06:34AM	Latest Updates of Viva Biotech's Portfolio Companies (PR Newswire)
Mar-01-24 04:01PM	Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire) +5.81%
06:49AM	Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains? (Zacks)
Feb-27-24 10:20PM	Absci Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:01PM	Absci Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Feb-21-24 07:30AM	Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI (GlobeNewswire)
Feb-20-24 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) -9.76%
09:40AM	Loading…
Feb-05-24 09:40AM	Is Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year? (Zacks) -9.93%
Jan-10-24 07:30AM	Absci Appoints Professor Sir Mene Pangalos to its Board of Directors (GlobeNewswire) +7.06%
Jan-08-24 07:00AM	Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +15.47%
Jan-03-24 08:00AM	Absci to Participate in the 26th Annual Needham Growth Conference (GlobeNewswire)
Dec-28-23 08:00AM	Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-23 07:30AM	Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline (GlobeNewswire)
Dec-05-23 08:11AM	Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy (Zacks) +8.16%
Dec-04-23 07:30AM	Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate (GlobeNewswire) +12.64%
06:18AM	AstraZeneca inks $247M, AI-enabled oncology antibody design pact, joining Absci's list of pharma allies (FierceBiotech.com)
Dec-03-23 01:27AM	AstraZeneca, AI biologics firm Absci tie up on cancer drug (Reuters)
01:22AM	UPDATE 2-AstraZeneca, AI biologics firm Absci tie up on cancer drug (Reuters)
12:21AM	AstraZeneca ties up with AI biologics company to develop cancer drug - FT (Reuters)
12:00AM	AstraZeneca ties up with AI biologics company to develop cancer drug (Financial Times)
Nov-15-23 08:00AM	Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-14-23 06:15PM	Absci Corp (ABSI) Reports Decrease in Q3 Revenue and Lower Net Loss Year-Over-Year (GuruFocus.com) +12.00%
04:05PM	Loading…
04:05PM	Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
02:16AM	Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases (Business Wire)
Oct-26-23 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-21-23 08:00AM	Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen (GlobeNewswire)
Sep-06-23 08:00AM	Absci to Host R&D Day on October 4, 2023 (GlobeNewswire)
Aug-28-23 04:05PM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-14-23 03:51PM	The 3 Most Undervalued Penny Stocks to Buy Now: August 2023 (InvestorPlace) +5.36%
08:02AM	Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results (GlobeNewswire)
08:00AM	Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer (GlobeNewswire)
Aug-10-23 08:00AM	Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development (GlobeNewswire)
Aug-01-23 08:00AM	Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023 (GlobeNewswire) -7.27%
Jul-26-23 08:00AM	Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jun-15-23 08:00AM	Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit (GlobeNewswire)
Jun-07-23 09:32AM	Shareholders in Absci (NASDAQ:ABSI) are in the red if they invested a year ago (Simply Wall St.)
Jun-06-23 08:00AM	Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips (GlobeNewswire)
May-15-23 05:45PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results (GlobeNewswire)
May-11-23 08:00AM	University of Oxfords Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies (GlobeNewswire) -5.34%
May-03-23 10:00AM	Absci Corporation (ABSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-06-23 08:00AM	Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-04-23 08:00AM	Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology (GlobeNewswire)
Apr-01-23 08:25AM	Absci Full Year 2022 Earnings: Revenues Disappoint (Simply Wall St.)
Mar-30-23 04:05PM	Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results (GlobeNewswire)
Mar-23-23 08:00AM	Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation (GlobeNewswire)
Mar-07-23 08:00AM	Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (GlobeNewswire)
06:08AM	Absci Corporation (NASDAQ:ABSI) has caught the attention of institutional investors who hold a sizeable 29% stake (Simply Wall St.)
Feb-28-23 08:00AM	Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland (GlobeNewswire)
Feb-21-23 08:00AM	Absci to Participate in the 43rd Annual Cowen Health Care Conference (GlobeNewswire) -8.99%
Feb-09-23 08:00AM	St. Johns Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies (GlobeNewswire) -5.08%
Feb-08-23 08:00AM	Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation (GlobeNewswire) -9.23%
Jan-10-23 10:36AM	10 Penny Stocks That Will Make You A Millionaire (Insider Monkey) +5.35%
10:00AM	Absci announces AI breakthrough in designing therapeutic antibodies (American City Business Journals)
08:00AM	Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI (GlobeNewswire)
Jan-08-23 03:13PM	Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-22 07:17AM	Absci (NASDAQ:ABSI) shareholders have endured a 76% loss from investing in the stock a year ago (Simply Wall St.) +7.18%
Dec-28-22 08:00AM	Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-23-22 08:00AM	Absci to Participate in the Berenberg Discover AI Seminar (GlobeNewswire)
Nov-17-22 08:00AM	Absci to Participate in the Piper Sandler Healthcare Conference (GlobeNewswire) -8.55%
Nov-09-22 10:47AM	Absci reports $27M loss but strong cash position (American City Business Journals)
09:15AM	Absci Corporation (ABSI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Absci Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-02-22 04:05PM	Absci to Participate in the Stifel Healthcare Conference (GlobeNewswire) -5.81%
08:00AM	Absci Welcomes Meta Senior Executive to Board of Directors (GlobeNewswire)
Oct-26-22 08:00AM	Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference (GlobeNewswire)
Oct-04-22 07:00AM	Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer (GlobeNewswire) +10.10%
Sep-28-22 06:44AM	Institutional owners may consider drastic measures as Absci Corporation's (NASDAQ:ABSI) recent US$46m drop adds to long-term losses (Simply Wall St.) +7.21%
Sep-01-22 08:00AM	Absci to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire) +6.82%
Aug-24-22 07:00AM	Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire)
Aug-15-22 04:00PM	Absci analysts mostly bullish after Q2 earnings, 'prudent' layoffs (American City Business Journals)
Aug-11-22 09:15AM	Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +14.05%
08:00AM	Absci Reports Second Quarter 2022 Financial Results and Business Update (GlobeNewswire)
Aug-10-22 10:50AM	Vancouver biotech firm Absci lays off employees, cites economy (American City Business Journals) +7.69%
08:19AM	The Zacks Analyst Blog Highlights Absci Axcella Health, Freeline Therapeutics Holdings, DICE Therapeutics and Pliant Therapeutics (Zacks)
Aug-02-22 11:17AM	2 Strong Buy Penny Stocks With Substantial Upside Potential (TipRanks)
Aug-01-22 08:00AM	Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference (GlobeNewswire)
Jul-26-22 02:23PM	Ex-Absci CTO's new startup tackling plastics recycling, accepted to Y Combinator (American City Business Journals)
Jul-22-22 07:25AM	Strong week for Absci (NASDAQ:ABSI) shareholders doesn't alleviate pain of one-year loss (Simply Wall St.) -6.13%
Jul-21-22 07:00AM	Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event (GlobeNewswire)
Jul-14-22 07:05AM	Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires (GlobeNewswire)
Jul-07-22 07:05AM	Absci Enters Multi-Program Collaboration with Emerging Biotech Partner (GlobeNewswire)
Jun-16-22 05:48PM	Absci stock gets slammed by macro conditions, rising interest rates (American City Business Journals) -5.80%
Jun-14-22 06:06PM	As markets pummel new Oregon companies, U. of Portland professor says 'hold on' (American City Business Journals) +5.06%
Jun-13-22 11:37AM	Monday market woes hit new Portland-area public companies hard (American City Business Journals)
11:37AM	Market woes hit new Portland-area public companies hard (American City Business Journals)
May-30-22 06:18AM	Favorable turn of events for Absci Corporation (NASDAQ:ABSI) insiders who've lost US$478k to date on a US$668k purchase (Simply Wall St.)
May-12-22 02:29PM	Absci reports first-quarter loss, reiterates guidance for the year (American City Business Journals)
May-11-22 08:00AM	Absci Reports First Quarter 2022 Financial and Operating Results (GlobeNewswire) -12.75%
May-03-22 08:55AM	10 Best Stocks to Buy Under $20 According to Jeremy Greens Redmile Group (Insider Monkey)
Apr-28-22 07:00AM	Absci to Participate in the BofA Securities 2022 Healthcare Conference (GlobeNewswire)
Apr-26-22 06:23PM	Absci's CEO on what lured the biotech to the Big Apple (American City Business Journals) -11.28%

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Redmile Group, LLC	Director	Mar 01 '24	Buy	4.50	222,222	999,999	8,253,316	Mar 05 09:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABSI

Absci Corp

Upgrade your FINVIZ experience